Latest Market News

Renergen Limited’s shares will be suspended from ASX trading on December 31, 2025, marking a key step in its acquisition by ASP Isotopes Inc. This suspension follows the formal implementation of a scheme of arrangement agreed earlier this month.

Robex Resources shareholders have overwhelmingly approved a merger with Predictive Discovery, setting the stage for a leading gold producer in West Africa with combined annual output projected to exceed 400,000 ounces by 2029.

Global X Management (AUS) Limited has released updated estimated distribution amounts for over 30 ETFs listed on the ASX AQUA Market for the period ending 31 December 2025, alongside key dates for investors to note.

Betashares Capital Ltd has released estimated distribution amounts for over 70 ETFs for the December 2025 period, highlighting income opportunities across a broad spectrum of funds. Investors should note key dates and the operation of the Distribution Reinvestment Plan.

Memphasys Limited has extended the repayment terms of its convertible notes with major shareholder Peters Investments to mid-2026, reinforcing financial flexibility amid ongoing commercial progress.

Coda Minerals has clarified that its recent share price and volume spike is driven by rising copper and silver prices, with no undisclosed company information influencing the market.

Papyrus Australia has taken a significant step towards commercialisation by signing a $4.2 million supply contract with TBS Mining Solutions for its biodegradable Collar Keeper® products, while advancing its Adelaide R&D facility.

Cazaly Resources has struck a deal with Dundas Minerals, allowing the latter to earn an 80% interest in the Romano gold project by funding $2 million in exploration over two years. Cazaly retains a 20% free-carried interest while focusing on its core Goongarrie project.

Toro Energy has secured a crucial Foreign Investment Review Board approval for its acquisition by IsoEnergy, moving the deal closer to completion. Shareholder and court approvals remain as the next steps.

Arovella Therapeutics has taken a significant step forward by submitting an IND application to the U.S. FDA for its lead CAR-iNKT cell therapy, ALA-101, targeting blood cancers. This milestone paves the way for a first-in-human Phase 1 trial in both Australia and the U.S.

IPD Group has acquired Platinum Cables Pty Ltd for $37.5 million, enhancing its mining sector footprint and delivering an 11.5% EPS accretion in FY25 pro forma. The deal positions IPD for expanded cross-selling and deeper customer ties with Australia's largest miners.

IPD Group Limited has agreed to acquire Platinum Cables Pty Ltd for $37.5 million upfront, enhancing its position in the mining sector and delivering an 11.5% accretion to FY25 earnings per share.